Evidence map›Paper›PMID 41062979›Full record

Observational studyBMC pregnancy and childbirth2025

Association of preconception cannabis use frequency with cannabis use during early pregnancy.

Kelly C Young-Wolff, Felicia W Chi, Cynthia I Campbell, Monique B Does, Christina N Wysota, Deborah Ansley, Carley Castellanos, Gwen T Lapham

Abstract readObservational Study
In one paragraph

Observational study in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kelly C Young-WolffDivision of Research, Kaiser Permanente Northern California, 4480 Hacienda Drive, Building B, Pleasanton, CA, 94588, USA. Kelly.c.young-wolff@kp.org.
Felicia W ChiDivision of Research, Kaiser Permanente Northern California, 4480 Hacienda Drive, Building B, Pleasanton, CA, 94588, USA.
Cynthia I CampbellDivision of Research, Kaiser Permanente Northern California, 4480 Hacienda Drive, Building B, Pleasanton, CA, 94588, USA.
Monique B DoesDivision of Research, Kaiser Permanente Northern California, 4480 Hacienda Drive, Building B, Pleasanton, CA, 94588, USA.
Christina N WysotaDepartment of Population Health, New York University, New York, NY, USA.
Deborah AnsleyRegional Offices, Kaiser Permanente Northern California, Pleasanton, CA, USA.
Carley CastellanosRegional Offices, Kaiser Permanente Northern California, Pleasanton, CA, USA.
Gwen T LaphamHealth Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.

Funding

Project-002UG1DA040314 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Ingrid A Binswanger, CYNTHIA I CAMPBELL · 2015 to 2026
$34.9M
Modes of Cannabis Administration and Polysubstance Use among Women Before and During PregnancyR01DA058201 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Kelly Corinne Young-Wolff · 2023 to 2026
$2.6M
Identifying Risk Factors for Prenatal Substance and Polysubstance UseK01DA043604 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI YOUNG-WOLFF, KELLY CORINNE · 2017 to 2021
$907k
National Institute on Drug Abuse, United States R01DA058201National Institute on Drug Abuse, United States UG1DA040314NIDA NIH HHS K01 DA043604NIDA NIH HHS K01DA043604NIDA NIH HHS R01 DA058201NIDA NIH HHS UG1 DA040314
6 · The paper itself

Abstract

backgroundCannabis use during pregnancy is increasingly common and is associated with adverse health outcomes for pregnant individuals and their offspring. Identifying preconception factors that are associated with prenatal cannabis use is critical to inform early prevention and intervention. This study tested whether frequency of preconception cannabis use was associated with cannabis use during early pregnancy using data from a large healthcare system with universal screening for cannabis use.

methodsThis observational study included pregnant individuals in Kaiser Permanente Northern California (KPNC) who self-reported any cannabis use (daily, weekly, or monthly or less) during the year before pregnancy from 2011 to 2022 (excluding 2020). Prenatal cannabis use was based on self-report and/or a positive toxicology test during the first trimester of pregnancy at entrance to prenatal care (at ~ 8 weeks gestation). Modified Poisson models were fit to assess associations between frequency of preconception cannabis use and prenatal cannabis use, adjusting for covariates.

resultsThe sample of 40,806 pregnancies from 36,622 unique individuals who self-reported any preconception cannabis use was 65.7% non-White; 27.6% were aged < 25 years. Nearly half (45.1%) screened positive for prenatal use, including 23.7% by self-report and 36.6% by positive toxicology test. Compared to monthly or less preconception cannabis use, daily use (adjusted prevalence ratio [aPR] = 2.66, 95% CI 2.59-2.73) or weekly use (aPR = 1.99, 95% CI 1.93-2.05) was associated with greater risk of prenatal cannabis use. Results were similar when prenatal cannabis use was based on self-report only or on toxicology testing only.

conclusionsGreater frequency of preconception cannabis use was associated with substantially increased risk of prenatal cannabis use. Findings reinforce the need for early harm prevention efforts focused on reducing the frequency of cannabis use among women of reproductive age, including screening, education, and early linkage to intervention.

Indexed as

Marijuana UseAdolescentAdultCaliforniaFemaleHumansPreconception CarePregnancyPregnancy Trimester, FirstPrenatal CareSelf ReportYoung AdultCannabisFrequencyMarijuanaPreconceptionPregnancy

Identifiers

PMID41062979
PMCPMC12506406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.